- Home
- Publications
- Publication Search
- Publication Details
Title
Clinical Implications of Exosomal PD-L1 in Cancer Immunotherapy
Authors
Keywords
-
Journal
Journal of Immunology Research
Volume 2021, Issue -, Pages 1-18
Publisher
Hindawi Limited
Online
2021-02-10
DOI
10.1155/2021/8839978
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Current issues and perspectives in PD-1 blockade cancer immunotherapy
- (2020) Kenji Chamoto et al. International Journal of Clinical Oncology
- Enhanced STAT3 phosphorylation and PD-L1 expression in myeloid dendritic cells indicate impaired IL-27Ralpha signaling in type 1 diabetes
- (2020) Z. Parackova et al. Scientific Reports
- Tracking the evolution of circulating exosomal-PD-L1 to monitor melanoma patients
- (2020) Marine Cordonnier et al. Journal of Extracellular Vesicles
- Exosomes in the Regulation of Vascular Endothelial Cell Regeneration
- (2020) Jugajyoti Baruah et al. Frontiers in Cell and Developmental Biology
- Role of tumor microenvironment in the regulation of PD-L1: A novel role in resistance to cancer immunotherapy
- (2020) Nirvana Kalantari Khandani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Exosomal PD-L1 induces immunosuppressive nonclassical monocytes
- (2020) Aaron A Diaz NEURO-ONCOLOGY
- anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells
- (2020) Shaochuan Liu et al. Cell Death & Disease
- The Biogenesis, Biology, and Clinical Significance of Exosomal PD-L1 in Cancer
- (2020) Yanyan Tang et al. Frontiers in Immunology
- 5-FU-Induced Upregulation of Exosomal PD-L1 Causes Immunosuppression in Advanced Gastric Cancer Patients
- (2020) Min Zhang et al. Frontiers in Oncology
- Extracellular Vesicles From Gastric Cancer Cells Induce PD-L1 Expression on Neutrophils to Suppress T-Cell Immunity
- (2020) Yinghong Shi et al. Frontiers in Oncology
- Anti-PD-1 Therapy Response Predicted by the Combination of Exosomal PD-L1 and CD28
- (2020) Chaoxu Zhang et al. Frontiers in Oncology
- Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway
- (2020) Dongwei Dou et al. Frontiers in Immunology
- The Mechanisms of PD-L1 Regulation in Non-Small-Cell Lung Cancer (NSCLC): Which Are the Involved Players?
- (2020) Giuseppe Lamberti et al. Cancers
- Age-dependent hypoxia-induced PD-L1 upregulation in patients with obstructive sleep apnoea
- (2019) Carolina Cubillos-Zapata et al. RESPIROLOGY
- CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
- (2019) Letizia Porcelli et al. Cancers
- Exosomes in the tumor microenvironment as mediators of cancer therapy resistance
- (2019) Irene Li et al. Molecular Cancer
- Effects of exosomes on pre-metastatic niche formation in tumors
- (2019) Yaxin Guo et al. Molecular Cancer
- PD-1/PD-L1 pathway: Basic biology and role in cancer immunotherapy
- (2019) Arash Salmaninejad et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Cancer‐associated fibroblasts promote PD‐L1 expression in mice cancer cells via secreting CXCL5
- (2019) Ziqian Li et al. INTERNATIONAL JOURNAL OF CANCER
- Enhancing tumor T cell infiltration to enable cancer immunotherapy
- (2019) Jin Zhang et al. Immunotherapy
- Endoplasmic Reticulum Stress Promotes Liver Cancer Cells to Release Exosomal miR-23a-3p and Up-regulate PD-L1 Expression in Macrophages
- (2019) Jiatao Liu et al. HEPATOLOGY
- Exosomal PD-L1 Retains Immunosuppressive Activity and is Associated with Gastric Cancer Prognosis
- (2019) Yibo Fan et al. ANNALS OF SURGICAL ONCOLOGY
- Exosomes in cancer development, metastasis, and immunity
- (2019) Lin Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
- (2019) Mauro Poggio et al. CELL
- FGFR2 Promotes Expression of PD-L1 in Colorectal Cancer via the JAK/STAT3 Signaling Pathway
- (2019) Piao Li et al. JOURNAL OF IMMUNOLOGY
- Exosomes: composition, biogenesis, and mechanisms in cancer metastasis and drug resistance
- (2019) Ladan Mashouri et al. Molecular Cancer
- CD8+ T cell exhaustion
- (2019) Makoto Kurachi Seminars in Immunopathology
- Combined Inhibition of TGF-β Signaling and the PD-L1 Immune Checkpoint Is Differentially Effective in Tumor Models
- (2019) Heng Sheng Sow et al. Cells
- Cancer immunotherapy: the art of targeting the tumor immune microenvironment
- (2019) Jesse Lopes da Silva et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- The Tumor Microenvironment Innately Modulates Cancer Progression
- (2019) Dominique C. Hinshaw et al. CANCER RESEARCH
- c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer
- (2019) Alexander Lux et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Expression of programmed death ligand (PD-L1) in different tumors. Comparison of several current available antibody clones and antibody profiling
- (2019) Svetlana Kintsler et al. Annals of Diagnostic Pathology
- PD-1 and PD-L1 correlated gene expression profiles and their association with clinical outcomes of breast cancer
- (2019) Cui Jiang et al. Cancer Cell International
- Exosomal PD-L1 promotes tumor growth through immune escape in non-small cell lung cancer
- (2019) Dong Ha Kim et al. EXPERIMENTAL AND MOLECULAR MEDICINE
- Human Monocyte Subsets and Phenotypes in Major Chronic Inflammatory Diseases
- (2019) Theodore S. Kapellos et al. Frontiers in Immunology
- PD-L1 Distribution and Perspective for Cancer Immunotherapy—Blockade, Knockdown, or Inhibition
- (2019) Yilun Wu et al. Frontiers in Immunology
- PD-L1 Induction by Cancer-Associated Fibroblast-Derived Factors in Lung Adenocarcinoma Cells
- (2019) Inoue et al. Cancers
- Clinical significance of PD-L1 expression in serum-derived exosomes in NSCLC patients
- (2019) Chuling Li et al. Journal of Translational Medicine
- Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer
- (2019) Koji Teramoto et al. LUNG CANCER
- The role of exosomal PD-L1 in tumor progression and immunotherapy
- (2019) Feiting Xie et al. Molecular Cancer
- Tumor stromal type is associated with stromal PD-L1 expression and predicts outcomes in breast cancer
- (2019) Qinglian Zhai et al. PLoS One
- CXCR5+PD-1+ follicular helper CD8 T cells control B cell tolerance
- (2019) Yuhong Chen et al. Nature Communications
- Inhibiting extracellular vesicles formation and release: a review of EV inhibitors
- (2019) Mariadelva Catalano et al. Journal of Extracellular Vesicles
- PD-L1 mRNA expression in plasma-derived exosomes is associated with response to anti-PD-1 antibodies in melanoma and NSCLC
- (2018) Marzia Del Re et al. BRITISH JOURNAL OF CANCER
- Combined VEGF and PD-L1 blockade displays synergistic treatment effects in an autochthonous mouse model of small cell lung cancer
- (2018) Lydia Meder et al. CANCER RESEARCH
- Exosomal PD-L1 harbors active defense function to suppress T cell killing of breast cancer cells and promote tumor growth
- (2018) Yi Yang et al. CELL RESEARCH
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- PD-1/PD-L1 in disease
- (2018) Nyanbol Kuol et al. Immunotherapy
- Expression of programmed death-ligand 1 and hypoxia-inducible factor-1α proteins in endometrial carcinoma
- (2018) AshrafIshak Fawzy Tawadros et al. Journal of Cancer Research and Therapeutics
- Host expression of PD-L1 determines efficacy of PD-L1 pathway blockade–mediated tumor regression
- (2018) Heng Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- Pembrolizumab versus paclitaxel for previously treated, advanced gastric or gastro-oesophageal junction cancer (KEYNOTE-061): a randomised, open-label, controlled, phase 3 trial
- (2018) Kohei Shitara et al. LANCET
- Cancer immunotherapy using checkpoint blockade
- (2018) Antoni Ribas et al. SCIENCE
- ALIX Regulates Tumor-Mediated Immunosuppression by Controlling EGFR Activity and PD-L1 Presentation
- (2018) James Monypenny et al. Cell Reports
- PD-1/PD-L1 pathway: an adaptive immune resistance mechanism to immunogenic chemotherapy in colorectal cancer
- (2018) Magalie Dosset et al. OncoImmunology
- Glioblastoma stem cell-derived exosomes induce M2 macrophages and PD-L1 expression on human monocytes
- (2018) Konrad Gabrusiewicz et al. OncoImmunology
- Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
- (2018) Franz L. Ricklefs et al. Science Advances
- Regulatory mechanisms of PD-L1 expression in cancer cells
- (2018) Yongyu Shi CANCER IMMUNOLOGY IMMUNOTHERAPY
- Exosomes Play Roles in Sequential Processes of Tumor Metastasis
- (2018) Keyu Li et al. INTERNATIONAL JOURNAL OF CANCER
- Type 1 IFN and PD-L1 Coordinate Lymphatic Endothelial Cell Expansion and Contraction during an Inflammatory Immune Response
- (2018) Erin D. Lucas et al. JOURNAL OF IMMUNOLOGY
- Exosomal PD-L1 contributes to immunosuppression and is associated with anti-PD-1 response
- (2018) Gang Chen et al. NATURE
- TGFβ attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells
- (2018) Sanjeev Mariathasan et al. NATURE
- Pembrolizumab plus Chemotherapy for Squamous Non–Small-Cell Lung Cancer
- (2018) Luis Paz-Ares et al. NEW ENGLAND JOURNAL OF MEDICINE
- Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
- (2018) Peixin Dong et al. Frontiers in Oncology
- A secreted PD-L1 splice variant that covalently dimerizes and mediates immunosuppression
- (2018) Kathleen M. Mahoney et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- CD8+ cytotoxic T lymphocytes in cancer immunotherapy: A review
- (2018) Bagher Farhood et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Monoclonal antibodies in cancer immunotherapy
- (2018) Ilgin Kimiz-Gebologlu et al. MOLECULAR BIOLOGY REPORTS
- Microenvironmental oxygen pressure orchestrates an anti- and pro-tumoral γδ T cell equilibrium via tumor-derived exosomes
- (2018) Ling Li et al. ONCOGENE
- Identification of CMTM6 and CMTM4 as PD-L1 protein regulators
- (2017) Riccardo Mezzadra et al. NATURE
- T-cell invigoration to tumour burden ratio associated with anti-PD-1 response
- (2017) Alexander C. Huang et al. NATURE
- CMTM6 maintains the expression of PD-L1 and regulates anti-tumour immunity
- (2017) Marian L. Burr et al. NATURE
- T cell costimulatory receptor CD28 is a primary target for PD-1–mediated inhibition
- (2017) Enfu Hui et al. SCIENCE
- Soluble PD-1 and PD-L1: predictive and prognostic significance in cancer
- (2017) Xinxin Zhu et al. Oncotarget
- Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 Expression
- (2017) Angel Garcia-Diaz et al. Cell Reports
- Soluble PD-L1 as a Biomarker in Malignant Melanoma Treated with Checkpoint Blockade
- (2017) Jun Zhou et al. Cancer Immunology Research
- PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome
- (2017) Hashem O. Alsaab et al. Frontiers in Pharmacology
- A novel bifunctional anti-PD-L1/TGF-β Trap fusion protein (M7824) efficiently reverts mesenchymalization of human lung cancer cells
- (2017) Justin M. David et al. OncoImmunology
- Genetic and Epigenetic Regulation of PD-1 Expression
- (2016) Alexander P. R. Bally et al. JOURNAL OF IMMUNOLOGY
- Tumor-Associated Macrophages and Neutrophils in Tumor Microenvironment
- (2016) Jaehong Kim et al. MEDIATORS OF INFLAMMATION
- Cancer-associated fibroblast exosomes regulate survival and proliferation of pancreatic cancer cells
- (2016) K E Richards et al. ONCOGENE
- Inhibitory receptors as targets for cancer immunotherapy
- (2015) Meghan E. Turnis et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- The Transcription Factor NFAT Promotes Exhaustion of Activated CD8 + T Cells
- (2015) Gustavo J. Martinez et al. IMMUNITY
- HIF-1 at the crossroads of hypoxia, inflammation, and cancer
- (2015) Kuppusamy Balamurugan INTERNATIONAL JOURNAL OF CANCER
- NF-κB Regulates PD-1 Expression in Macrophages
- (2015) Alexander P. R. Bally et al. JOURNAL OF IMMUNOLOGY
- PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy
- (2015) S. P. Patel et al. MOLECULAR CANCER THERAPEUTICS
- Circulating PD-L1 in NSCLC patients and the correlation between the level of PD-L1 expression and the clinical characteristics
- (2015) Jie Zhang et al. Thoracic Cancer
- Analysis of ESCRT functions in exosome biogenesis, composition and secretion highlights the heterogeneity of extracellular vesicles
- (2013) Marina Colombo et al. JOURNAL OF CELL SCIENCE
- Hypoxic enhancement of exosome release by breast cancer cells
- (2012) Hamish W King et al. BMC CANCER
- Molecular mechanisms and clinical applications of angiogenesis
- (2011) Peter Carmeliet et al. NATURE
- T cell exhaustion
- (2011) E John Wherry NATURE IMMUNOLOGY
- Cancer Exosomes Trigger Fibroblast to Myofibroblast Differentiation
- (2010) J. Webber et al. CANCER RESEARCH
- Rab27a and Rab27b control different steps of the exosome secretion pathway
- (2009) Matias Ostrowski et al. NATURE CELL BIOLOGY
- Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics
- (2009) G L Semenza ONCOGENE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More